Register entry

BUDDATE Co Ltd

Data as of · How to read this entry

Registered sites
1
Active NDC listings
3
Live patents
0
Countries
1
Base
South Korea
Authorisation

Registered operations

Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
BUDDATE Co LtdRm B-2508 25/F 606 Seobusaet-gil, Geumcheon-gu, Seoul, 08504, Korea, South (KOR)Labelling, Finished drug manufacture, Packaging3013702113694462588
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human otc drug. By marketing category: UNAPPROVED DRUG OTHER 3.

Dosage formNDCs
liquid2
cream1
RouteNDCs
topical3
Labeller name on the listingNDCs
buddate co ltd3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
BUDDATE INONOTUS OBLIQUUS WATER BRILLIANCE MASKButylene Glycol, Glycerin, Inonotus Obliquus (Mushroom) Extractliquid, topical71173-1000UNAPPROVED DRUG OTHER
BUDDATE LOTUS MOISTURE ESSENCEGlycerin, Niacinamide, Nelumbo Nucifera Flower Extract, Portulaca Oleracea Extractliquid, topical71173-2000UNAPPROVED DRUG OTHER
BUDDATE REGES INTENSIVE TREATMENTButylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7cream, topical71173-3000UNAPPROVED DRUG OTHER
Compare

Comparable companies in South Korea

Enquiry

Common questions

Is BUDDATE Co Ltd FDA approved?
BUDDATE Co Ltd holds 1 FDA-registered establishment in South Korea. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are BUDDATE Co Ltd's drugs manufactured?
The FDA register lists 08504. Registered operations: labelling, finished drug manufacture, packaging.
What drugs does BUDDATE Co Ltd make?
3 products are listed under BUDDATE Co Ltd in the openFDA NDC Directory, most often as liquid; cream. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.